🤑 It doesn’t get more affordable. Grab this 60% OFF Black Friday offer before it disappears…CLAIM SALE

Magle Chemoswed Holding Ab (MAGLE)

Stockholm
Currency in SEK
33.20
+1.32(+4.14%)
Closed
MAGLE Scorecard
Full Analysis
Impressive gross profit margins
Fair Value
Day's Range
32.6033.60
52 wk Range
24.0049.80
Key Statistics
Edit
Prev. Close
33.2
Open
32.6
Day's Range
32.6-33.6
52 wk Range
24-49.8
Volume
1.68K
Average Volume (3m)
1.58K
1-Year Change
37.19%
Book Value / Share
unlockUnlock
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MAGLE Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Magle Chemoswed Holding Ab Company Profile

Magle Chemoswed Holding AB (publ), together with its subsidiaries, operates as a contract development and manufacturing organization that serves pharmaceutical and medical device industry on a contract basis in Sweden. It provides warfarin sodium products used as anticoagulants for multiple indications; melperone hydrochloride, which is an antipsychotic agent; isradipine, a calcium channel blocker used to treat hypertension; amantadine sulfate that is used in the treatment of central nervous system disorders; and benserazide hydrochloride, which is used in combination with L-Dopa in the treatment of Parkinson’s disease. The company also offers EmboCept S, a microsphere-based medical device used in vascular occlusion of liver and lung tumors; SmartGel, a non-allergenic hydrogel based on the company’s microsphere technology; and SmartPAN, a medical device for the detection of pancreatic fluid leakage during open or minimally invasive surgical procedures. In addition, it is developing EmboCept M for the treatment of benign prostatic hyperplasia; EmboCept L for the treatment of uterine fibroids; SmartGel II, an advanced wound care hydrogel for the removal and prevention of wound biofilm; and SmartBone, an advanced formulation of microspheres in combination with active ingredients for stimulation of bone growth in surgical implant procedures. The company was founded in 1944 and is based in Malmö, Sweden. Magle Chemoswed Holding AB (publ) is a subsidiary of Magle AB.

Employees
78
Market
Sweden

Compare MAGLE to Peers and Sector

Metrics to compare
MAGLE
Peers
Sector
Relationship
P/E Ratio
36.5x−1.9x−0.7x
PEG Ratio
0.35−0.050.00
Price/Book
1.3x3.2x2.6x
Price / LTM Sales
2.9x5.8x3.2x
Upside (Analyst Target)
44.6%68.1%44.5%
Fair Value Upside
Unlock5.6%6.6%Unlock

FAQ

What Is the Magle Chemoswed (MAGLE) Stock Price Today?

The Magle Chemoswed stock price today is 33.20

What Stock Exchange Does Magle Chemoswed Trade On?

Magle Chemoswed is listed and trades on the Stockholm stock exchange.

What Is the Stock Symbol for Magle Chemoswed?

The stock symbol for Magle Chemoswed is "MAGLE."

What Is the Magle Chemoswed Market Cap?

As of today, Magle Chemoswed market cap is 610.94M.

What is Magle Chemoswed Earnings Per Share?

The Magle Chemoswed EPS is 1.55.

What Is the Next Magle Chemoswed Earnings Date?

Magle Chemoswed will release its next earnings report on Feb 26, 2025.

From a Technical Analysis Perspective, Is MAGLE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.